Sichenzia Ross Friedman Ference LLP Advises Cell Source, Inc. on $500,000 PIPE Financing
New York, NY – April 1, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Cell Source, Inc. (OTCQB: CLCS), a biomedical technology company focused on developing cell therapy treatments, on an offering pursuant to which Cell Source issued and sold two promissory notes in the aggregate amount of $500,000 and two Warrants to purchase common stock to two accredited investors.
The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia and Associate Jay Yamamoto.
Media Contact:
pr@srf.law
(212)-930-9700
- Sichenzia Ross Ference Carmel LLP (思成律师事务所/SRFC) 代表 Ribbon Acquisition Corp 完成在纳斯达克交易所5000万美元的首次公开发行 (IPO) - January 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management in $600,000 Public Offering of Giftify, Inc. - January 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $15 Million Public Offering of Li-Cycle - January 15, 2025